Amdocs (NASDAQ:DOX – Get Free Report) was downgraded by research analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a research note issued to investors on Monday, Zacks reports.
Other analysts also recently issued reports about the stock. Stifel Nicolaus decreased their price objective on shares of Amdocs from $71.00 to $46.00 and set a “buy” rating on the stock in a research report on Wednesday, November 4th. Weiss Ratings upgraded shares of Amdocs from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, October 23rd. Oppenheimer downgraded shares of Amdocs from an “outperform” rating to a “market perform” rating in a report on Wednesday, November 4th. Finally, Wall Street Zen lowered Amdocs from a “buy” rating to a “hold” rating in a research note on Saturday. Three investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $78.33.
Check Out Our Latest Stock Analysis on DOX
Amdocs Trading Down 0.7%
Amdocs stock opened at $41.46 on Monday. Amdocs has a 12-month low of $39.96 and a 12-month high of $85.63. The firm has a market capitalization of $4.48 billion, a price-to-earnings ratio of 6.30, a P/E/G ratio of 1.36 and a beta of 0.42. The firm has a 50 day moving average of $58.64 and a 200 day moving average of $61.57. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 0.23.
Amdocs (NASDAQ:DOX – Get Free Report) last issued its quarterly earnings results on Tuesday, November 3rd. The technology company reported $1.98 earnings per share for the quarter, meeting the consensus estimate of $1.98. The business had revenue of $1.19 billion for the quarter, compared to the consensus estimate of $1.19 billion. Amdocs had a net margin of 10.59% and a return on equity of 20.81%. The company’s revenue for the quarter was up 3.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.83 earnings per share. As a group, research analysts predict that Amdocs will post 5.82 earnings per share for the current year.
Institutional Trading of Amdocs
A number of institutional investors and hedge funds have recently bought and sold shares of DOX. Composition Wealth LLC bought a new stake in shares of Amdocs in the third quarter worth about $309,000. Voya Investment Management LLC lifted its position in shares of Amdocs by 155.6% in the third quarter. Voya Investment Management LLC now owns 28,213 shares of the technology company’s stock worth $1,613,000 after buying an additional 17,173 shares in the last quarter. Public Sector Pension Investment Board bought a new position in Amdocs during the third quarter valued at approximately $3,281,000. Global Retirement Partners LLC boosted its stake in Amdocs by 16.8% during the third quarter. Global Retirement Partners LLC now owns 2,007 shares of the technology company’s stock valued at $115,000 after buying an additional 289 shares during the last quarter. Finally, Rothschild Investment LLC grew its holdings in Amdocs by 296.2% during the 3rd quarter. Rothschild Investment LLC now owns 1,240 shares of the technology company’s stock valued at $71,000 after buying an additional 927 shares in the last quarter. 92.02% of the stock is currently owned by institutional investors.
Key Amdocs News
Here are the key news stories impacting Amdocs this week:
- Positive Sentiment: Amdocs said it was named a Leader in Gartner’s 2026 Magic Quadrant for CSP AI-enabled marketing and sales solutions, a potentially supportive signal for its product positioning. Article: Amdocs Named a Leader in the 2026 Gartner Magic Quadrant
- Neutral Sentiment: A short-interest report says short interest totaled zero shares as of November 10, despite describing a significant increase. The figures appear inconsistent and provide no clear indication of short-selling pressure.
- Negative Sentiment: Multiple law firms announced investigations into potential securities claims related to Amdocs’ disclosures and T-Mobile agreement issues. The reports cite the roughly 30% stock decline on November 4 after the company projected a 7%–11% revenue decline in fiscal 2027 amid an escalating T-Mobile dispute. The investigations may prolong uncertainty for investors. Article: Pomerantz investigation Article: Block & Leviton investigation Article: BFA Law investigation
- Negative Sentiment: Zacks added DOX to its Rank #5 (Strong Sell) list, reinforcing a bearish analyst signal. Article: New Strong Sell Stocks for November 10th
Amdocs Company Profile
Amdocs provides software and services to communications and media companies. Its offerings include business and operational support systems for billing, customer management, service delivery and network operations, as well as cloud and digital solutions that help clients modernize their businesses and improve customer experiences. Founded in 1982, Amdocs serves communications and media providers in markets around the world. The company is headquartered in the St. Louis, Missouri, area and is led by President and Chief Executive Officer Shuky Sheffer.
Further Reading
- Five stocks we like better than Amdocs
- The Trade Desk Beats on Revenue, But the Fine Print Matters
- Poll Reveals: Which States Are Most Prepared for a Crisis? [2026]
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
